Download this PDF guide outlining key information on HCC risk assessment, screening, and surveillance in the setting of Hepatitis B infection.
Gain expert insight on practical approaches to HCC risk assessment, HCC screening and surveillance, and HCC management in the setting of patients with hepatitis B.
Watch this dynamic panel discussion on HCC risk, screening, surveillance, and management, in the setting of patients with hepatitis B.
亚太地区在评估 HBV 患者的 HCC 风险和跨学科管理方面的注意事项
Asia-Pacific considerations in assessing HCC risk in patients with HBV and interdisciplinary management of HCC.
Patients achieving a functional cure for chronic hepatitis B with nucleos(t)ide analogue treatment may still develop HCC. What tools do we have to predict which patients will experience progression of liver disease?
ヌクレオチ(シ)ド類似物治療によって慢性B型肝炎の機能的治癒を達成している患者さんでも、HCCが発生する可能性があります。患者さんが肝臓疾患の進行を経験するかを予測するためには、どのようなツールがあるでしょうか?
HCC risk scores can inform a personalized approach to HCC surveillance in patients with chronic hepatitis B by allowing patients at very low risk to avoid burdensome surveillance and identifying high-risk patients who may benefit from intensive surveillance
Learn from Grace LH Wong, MD, about prevention and treatment of HBV-related HCC in the Asia-Pacific region, where more than 75% of the global population with HBV resides.
世界のHBV 罹患者の 75% 超が在住する、アジア太平洋地域における HBV-関連の HCC の予防と治療について Grace LH Wong, MDから学ぶ
向医学博士 Grace LH Wong 了解亚太地区 HBV 相关 HCC 的预防和治疗,全球 HBV 感染者中有超过 75% 居住在该地区。
In these slides, expert faculty discusses Asia-Pacific considerations relevant to patients with HCC in the setting of hepatitis B.
在这些幻灯片中,专家教员讨论了与乙型肝炎环境中的 HCC 患者相关的亚太地区注意事项。
これらのスライドでは、専門家教授が、B 型肝炎の状況における HCC 患者に妥当なアジア太平洋地域の考慮点ついて協議します。
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.